CORZZ: Core Scientific Files Exhibit 99.1 Reporting Q2 2025 Earnings

Rhea-AI Filing Summary

Core Scientific, Inc. furnished a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. The press release is provided as Exhibit 99.1 to this Current Report and is incorporated by reference into Items 2.02 and 7.01 of the filing. The company states that the information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference in Securities Act filings.

The 8-K itself does not include the underlying financial metrics or operational detail; readers must review Exhibit 99.1 for the actual results. The filing also lists the registrant's exchange-listed securities: common stock CORZ and warrants CORZW and CORZZ.

Insights

Financial Analyst

TL;DR Furnished Q2 results announced; no numbers in the 8-K, so immediate market impact is neutral until Exhibit 99.1 is reviewed.

The Current Report notifies investors that Core Scientific issued a press release covering results for the quarter ended June 30, 2025, and furnished that release as Exhibit 99.1. Because the 8-K text does not include revenue, profit, cash flow, or guidance figures, it provides notice but no actionable financial detail. The company explicitly states the release is "furnished" and not "filed," which limits incorporation risk. Impact rating: 0

Corporate Governance Expert

TL;DR The filing is a routine Regulation FD/Item 2.02 disclosure furnishing an earnings release; the form itself reports no material changes.

The report follows standard disclosure practice by furnishing an earnings press release under Items 2.02 and 7.01 and clarifying that the materials are furnished, not filed. As presented, the form does not disclose executive changes, material transactions, or amendments to governance documents. From a governance and compliance perspective the 8-K documents public disclosure without creating new incorporation liabilities. Impact rating: 0

0001839341FALSECore Scientific, Inc./tx838 Walker RoadSuite 21-2105DoverDelaware00018393412025-08-082025-08-080001839341us-gaap:CommonStockMember2025-08-082025-08-080001839341core:WarrantExercisePriceOf6.81PerShareMember2025-08-082025-08-080001839341core:WarrantExercisePriceOf0.01PerShareMember2025-08-082025-08-08

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 8, 2025

Core Scientific, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-40046

86-1243837

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

838 Walker Road, Suite 21-2105 Dover, Delaware						19904
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (512) 402-5233

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, par value $0.00001 per share			CORZ			The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $6.81 per share			CORZW			The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $0.01 per share			CORZZ			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02    Results of Operations and Financial Condition

On August 8, 2025, the Company issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01    Regulation FD Disclosure

The information contained in Item 2.02 is incorporated herein by reference.

The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01    Financial Statement and Exhibits

(d) Exhibits:

Exhibit No.						Description
99.1						Press Release dated August 8, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Core Scientific, Inc.
Dated: August 8, 2025
			By:			/s/ Todd M. DuChene
			Name:			Todd M. DuChene
			Title:			Chief Legal Officer and Chief Administrative Officer

FAQ

What did Core Scientific (CORZZ) disclose in this 8-K?

The company furnished a press release announcing financial results for the second fiscal quarter ended June 30, 2025.

Where can I find the press release referenced in the 8-K for CORZZ?

The press release is attached as Exhibit 99.1 to the Current Report dated August 8, 2025.

Is the information in this 8-K "filed" with the SEC?

No. The company states the information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" or incorporated by reference.

Which securities of Core Scientific are listed in this filing?

Common stock: CORZ; Warrants exercisable at $6.81: CORZW; Warrants exercisable at $0.01: CORZZ.

Does the 8-K include financial figures for the quarter?

No. The 8-K references a press release for the quarter's results but does not include the underlying financial metrics in the filing text.